The driver role of JAK‐STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy‐ and castration‐resistant prostate cancer

Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma

(2020) Paola Ostano et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies

(2020) Shihori Tanabe et al.   Frontiers in Pharmacology

N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway

(2019) Yu Yin et al.   Molecular Cancer

BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1

(2019) Jing Hu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The roles and mechanism of IFIT5 in bladder cancer epithelial–mesenchymal transition and progression

(2019) Jun Huang et al.   Cell Death & Disease

Elevating SOX2 in prostate tumor cells upregulates expression of neuroendocrine genes, but does not reduce the inhibitory effects of enzalutamide

(2019) Ethan P. Metz et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The paracrine induction of prostate cancer progression by caveolin-1

(2019) Chun-Jung Lin et al.   Cell Death & Disease

IFNL4-ΔG allele is associated with an interferon signature in tumors and survival of African-American men with prostate cancer

(2018) Wei Tang et al.   CLINICAL CANCER RESEARCH

Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis

(2018) Christopher J.D. Wallis et al.   EUROPEAN UROLOGY

OUP accepted manuscript

(2018)   JNCI-Journal of the National Cancer Institute

OUP accepted manuscript

(2018)   JNCI-Journal of the National Cancer Institute

Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells

(2018) Hisham F. Bahmad et al.   Frontiers in Oncology

IFN-r-induced IFIT5 promotes epithelial-to-mesenchymal transition in prostate cancer via microRNA processing

(2018) U-Ging Lo et al.   CANCER RESEARCH

SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer

(2017) Ping Mu et al.   SCIENCE

Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance

(2017) Sheng Yu Ku et al.   SCIENCE

N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer

(2016) Etienne Dardenne et al.   CANCER CELL

Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer

(2016) Dingxiao Zhang et al.   Nature Communications

Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer

(2016) Chengfei Liu et al.   Oncotarget

Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer

(2015) K L Mahon et al.   BRITISH JOURNAL OF CANCER

Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers

(2015) A. M. Aparicio et al.   CLINICAL CANCER RESEARCH

SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer

(2015) X. Zhang et al.   CLINICAL CANCER RESEARCH

Identification and Functional Validation of Reciprocal microRNA-mRNA Pairings in African American Prostate Cancer Disparities

(2015) B.-D. Wang et al.   CLINICAL CANCER RESEARCH

Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition

(2015) Chengfei Liu et al.   PROSTATE

Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal TreatmentRelated Neuroendocrine Prostate Cancer

(2015) Juan Miguel Mosquera et al.   NEOPLASIA

miRNA-128 Suppresses Prostate Cancer by Inhibiting BMI-1 to Inhibit Tumor-Initiating Cells

(2014) M. Jin et al.   CANCER RESEARCH

IFIT5 potentiates anti-viral response through enhancing innate immune signaling pathways

(2013) B. Zhang et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

tRNA Binding, Structure, and Localization of the Human Interferon-Induced Protein IFIT5

(2013) George E. Katibah et al.   MOLECULAR CELL

Enrichment of putative prostate cancer stem cells after androgen deprivation: Upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines

(2013) Daniel Seiler et al.   PROSTATE

Increased expression of putative cancer stem cell markers in the bone marrow of prostate cancer patients is associated with bone metastasis progression

(2013) Estelle Ricci et al.   PROSTATE

Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties

(2012) Linlin Zhang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation

(2011) C R Jeter et al.   ONCOGENE

SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell

(2011) X. Jia et al.   Journal of Molecular Cell Biology

Serum cytokine profiles in patients with prostate carcinoma

(2011) ERI TAZAKI et al.   Experimental and Therapeutic Medicine

Progressive epithelial to mesenchymal transitions in ARCaPEprostate cancer cells during xenograft tumor formation and metastasis

(2009) Hui He et al.   PROSTATE

An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer

(2008) R. R. Weichselbaum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA